BioSpace News Archive

Merck (NYSE:MRK), known as MSD outside the United States and Canada, has a long history of responsible pricing. In 2017, Merck issued its second annual Pricing Action Transparency Report, which showed that net prices across Merck’s U.S. product portfolio declined by 1.9 percent...

Ferring Pharmaceuticals, Inc.. today announced that the U.S. Food and Drug Administration (FDA) has approved ZOMACTON (somatropin) for injection in four additional pediatric indications:

The 15th annual BIO World Congress on Industrial Biotechnology concluded today at the Pennsylvania Convention Center in Philadelphia.

Statement from Commissioner Scott Gottlieb, M.D.; Peter Marks, M.D., Ph.D., director, Center for Biologics Evaluation and Research; and Janet Woodcock, M.D., director, Center for Drug Evaluation and Research

First Amgen Collaboration With Academic Medical Center Focused on Research, Health Service Redesign and Outcomes-Based Care

Alkermes plc will host a conference call and webcast presentation at 8:30 a.m. ET (1:30 p.m. BST) on Thursday, July 26, 2018, to discuss the company’s second quarter 2018 financial results.

Unity Health Care announced the official launch of its new organizational rebrand and redesigned website, UnityHealthCare.org.

Provention Bio, Inc. (Nasdaq:PRVB), a clinical stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, announced today the closing of its initial public offering of shares of its common stock at a public offering price of $4.00 per share on July 19, 2018.

PTC Therapeutics, Inc., today announced that it has entered into an agreement to acquire Agilis Biotherapeutics, Inc., a biotechnology company advancing an innovative gene therapy platform for rare monogenic diseases that affect the central nervous system (CNS). The transaction was approved by the Boards of both companies.

Universal Health Services, Inc. announced that its Board of Directors voted to pay a cash dividend of $0.10 per share on September 17, 2018 to shareholders of record as of September 4, 2018.